Literature DB >> 1329845

Congenital cytomegalovirus infection in Korean population with very high prevalence of maternal immunity.

Y M Sohn1, K I Park, C Lee, D G Han, W Y Lee.   

Abstract

In order to asses congenital cytomegalovirus (CMV) infection in Korea, five hundred and seventy five pregnant women (mean age 29.5 +/- 3.8 yrs., mean gestational age at test 37.5 +/- 6.7 weeks) visiting the prenatal clinic at Severance Hospital, Seoul, Korea were studied. CMV IgG antibody was present in 96% (552/575) and IgM antibody was present in 0.7% (4/575) of the pregnant women by the third trimester. Four of 445 cord sera were positive for CMV IgM antibody (0.9%). Urine samples from 514 newborns were tested for the evaluation of congenital CMV infection. Six (1.2%) of 514 newborns excreted CMV in their urine. All the congenitally infected infants had subclinical involvement at birth and during the 12 months of the follow-up period. These results indicate that Korean pregnant women were highly immunized against CMV by the third trimester. Furthermore this study suggests that the rate of congenital CMV infection is relatively as high as rates previously reported from other countries, although there is a very high prevalence of maternal immunity. The incidence of maternal primary infection during pregnancy seems to be rare and therefore most congenital infections in Korea might be following by maternal reactivation or reinfection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329845      PMCID: PMC3053812          DOI: 10.3346/jkms.1992.7.1.47

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  17 in total

1.  Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer.

Authors:  J-H Ko; K R Peck; W J Lee; K Huh; J R Yoo; K Kim; S Y Cho; Y E Ha; C-I Kang; D R Chung; C W Jung; Y-H Kim; N Y Lee; K-M Kim; J-H Song
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-23       Impact factor: 3.267

Review 2.  Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.

Authors:  Tatiana M Lanzieri; Sheila C Dollard; Stephanie R Bialek; Scott D Grosse
Journal:  Int J Infect Dis       Date:  2014-03-12       Impact factor: 3.623

3.  Acute cytomegalovirus infection in Kenyan HIV-infected infants.

Authors:  Jennifer A Slyker; Barbara L Lohman-Payne; Grace C John-Stewart; Elizabeth Maleche-Obimbo; Sandra Emery; Barbra Richardson; Tao Dong; Astrid Kn Iversen; Dorothy Mbori-Ngacha; Julie Overbaugh; Vincent C Emery; Sarah L Rowland-Jones
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

4.  Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.

Authors:  Marisa M Mussi-Pinhata; Aparecida Y Yamamoto; Rosângela M Moura Brito; Myriam de Lima Isaac; Patricia F de Carvalho e Oliveira; Suresh Boppana; William J Britt
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

Review 5.  Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.

Authors:  Sallie R Permar; Mark R Schleiss; Stanley A Plotkin
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

6.  Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.

Authors:  Meghan K Eberhardt; W L William Chang; Naomi J Logsdon; Yujuan Yue; Mark R Walter; Peter A Barry
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

Review 7.  Exploiting viral natural history for vaccine development.

Authors:  Peter A Barry
Journal:  Med Microbiol Immunol       Date:  2015-03-21       Impact factor: 3.402

8.  Comparison of FcRγ-Deficient and CD57+ Natural Killer Cells Between Cord Blood and Adult Blood in the Cytomegalovirus-Endemic Korean Population.

Authors:  Hee Jo Baek; Da-Woon Kim; Minh-Trang Thi Phan; Ju-Sun Kim; Ji-Hoon Yang; Jeong Il Choi; Je-Jung Lee; Myung-Geun Shin; Dong-Wook Ryang; Sang-Ki Kim; Seung-Hwan Lee; Hoon Kook; Duck Cho
Journal:  Ann Lab Med       Date:  2015-05-21       Impact factor: 3.464

Review 9.  Using the nonhuman primate model of HCMV to guide vaccine development.

Authors:  Jesse D Deere; Peter A Barry
Journal:  Viruses       Date:  2014-03-27       Impact factor: 5.048

10.  Pathogenesis of HSV and CMV Infections in Pregnancy.

Authors:  M Askienazy-Elbhar; C Sifer
Journal:  Infect Dis Obstet Gynecol       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.